Interleukin-10 controls the onset of irreversible septic shock

Infection and Immunity

Volumn 70, Issue 8, 2002, Pages 4441-4446

  Latifi, Samir Q ^a   O'Riordan, Mary Ann ^a   Levine, Alan D ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL INFECTION; LETHALITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SURGERY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; KINETICS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECOMBINANT PROTEINS; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036073338     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.8.4441-4446.2002     Document Type: Article

References (32)

1. Evaluations of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model
2. Severe sepsis and septic shock: Definitions, epidemiology, and clinical manifestations
3. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance
4. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin
5. The physiologic basis for anticytokine clinical trials in the treatment of sepsis
6. Sepsis and serum cytokine concentrations
7. Pediatric sepsis and multiple organ dysfunction syndrome
8. The compensatory anti-inflammatory cytokine interleukin 10 response in pediatric sepsis-induced multiple organ failure
9. Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure
10. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia
11. Blood interleukin 10 levels parallel the severity of septic shock
12. + T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α
13. Randomized, placebo-controlled trial of the antitumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES study
14. Characterization of a hyperdynamic murine model of resuscitated sepsis using echocardiography
15. Interleukin 10 protects mice from lethal endotoxemia
16. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers
17. Interleukin 10 reduces mortality from severe peritonitis in mice
18. Effect of volume support, antibiotic therapy, and monoclonal antiendotoxin antibodies on mortality rate and blood concentrations of endothelin and other mediators in fulminant intraabdominal sepsis in rats
19. Endotoxin and tumor necrosis factor do not cause mortality from caecal ligation and puncture
20. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS, plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time
21. Molecular biology of septic shock
22. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock
23. Efficacy of tribromoethanol anesthesia in mice
24. Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis
25. Comparison of the mortality and inflammatory response of two models of sepsis: Lipopolysaccharide versus cecal ligation and puncture
26. Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis
27. IL-10 deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance
28. What is the role of interleukin 10 in polymicrobial sepsis: Anti-inflammatory agent or immunosuppressant?
29. Correlation of plasma cytokine elevations with mortality rate in children with sepsis
30. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: Sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13
31. Endogenous IL-10 protects mice from death during septic peritonitis
32. Fluid resuscitation attenuates early cytokine mRNA expression after peritonitis